Weekly Round-Up

  • Read more: Petrie-Flom Intern’s Weekly Round-Up, 4/18-4/25

    Petrie-Flom Intern’s Weekly Round-Up, 4/18-4/25

    By Chloe Reichel This Thursday the Food and Drug Administration (FDA) proposed new regulations for the sale of e-cigarettes. These regulations would prohibit sales to minors and make health warnings on packages mandatory. This Wednesday a law was passed in Vermont that requires the labeling of genetically modified foods. Vermont is the first state to…

  • Read more: Petrie-Flom Intern’s Weekly Round-Up, 3/21-3/28

    Petrie-Flom Intern’s Weekly Round-Up, 3/21-3/28

    By Chloe Reichel The Hobby Lobby case that is currently before the Supreme Court may have effects far beyond the contraceptives mandate stemming from the Affordable Care Act. Other health care services and non-discrimination provisions may also be at stake. Deadlines will be extended for people who need more time to complete their enrollment in…

  • Read more: Petrie-Flom Intern’s Weekly Round-Up, 2/28-3/7

    Petrie-Flom Intern’s Weekly Round-Up, 2/28-3/7

    By Chloe Reichel The majority of people in La Crosse, Wisconsin have advance directives. The initiative to increase the utilization of advance care planning began as a way of helping patients, but resulted in large decreases in health care expenditures. Due to Texas’ recently passed regulations on abortion clinics, two clinics closed this week. Abortion…

  • Read more: Petrie-Flom Interns’ Weekly Round-Up, 2/14-2/21

    Petrie-Flom Interns’ Weekly Round-Up, 2/14-2/21

    By Chloe Reichel 1) Belgium’s recent vote to legalize euthanasia for children has drawn international debate and criticism. The law would allow terminally ill children to end their lives, provided that they have parental consent. 2) Lawmakers in California have proposed adding a warning label on soda and juice that has sugar added and over…

  • Read more: Petrie-Flom Interns’ Weekly Round-Up, 1/31-2/7

    Petrie-Flom Interns’ Weekly Round-Up, 1/31-2/7

    By Chloe Reichel 1) On February 11, the FDA will launch its “Real Cost,” anti-smoking campaign. The $115-million campaign is geared toward discouraging teenagers from smoking by emphasizing the “personally relevant” effects of smoking. 2) Lawsuits against the manufacturer of Pradaxa, Boehringer Ingelheim, have revealed internal documents about the dangers of the drug. The drug, a blood thinner,…